Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of QP001 injection for moderate to severe pain after orthopedic surgery
ChiCTR2200063601Phase 3Not yet recruiting
- Sponsor
- Third Xiangya Hospital, Central South University
- Start
- Sep 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of QP001 in postoperative pain (2 arms), sponsored by Third Xiangya Hospital, Central South University. Primary endpoint: NRS pain intensity score. Planned start Sep 2022; status: not yet recruiting.
02
Drugs
QP001
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2200063601.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200063601.